Author: Scientific Malaysian

Event Report on the 13th UN Convention on Biological Diversity 2016 – “Synthetic Biology, Meet Traditional Knowledge”

Event Report on the 13th UN Convention on Biological Diversity 2016 – “Synthetic Biology, Meet Traditional Knowledge”

Megadiverse countries are worried that commercially valuable DNA sequences stored digitally would allow access to anyone without needing physical access to the genetic resources. This could lead to biopiracy, where such information could be exploited without any benefits flowing back into the source country. The greatest fear, perhaps, is how these products could be commercialised, patented, then sold back to the original countries as food, drugs, or other necessities.

High Impact Articles – January 2017

High Impact Articles – January 2017

The High Impact Articles column is a space where we highlight scientific publications by Malaysian authors. Do let us know via our contact form if you come across any high impact articles by Malaysian scientists and we will feature them in this section! Title of published […]

Microscale Chemistry: Small tools, big fun!

Microscale Chemistry: Small tools, big fun!

Microscale Chemistry was first introduced by Egerton Grey in 1928. However, this approach only started to gain interest 20 years ago.

SciMy Interview: Mr Mohd Izmir Yamin of the Malaysian Independence-X team at Google Lunar XPRIZE

SciMy Interview: Mr Mohd Izmir Yamin of the Malaysian Independence-X team at Google Lunar XPRIZE

The Google Lunar XPRIZE (GLXP) is the largest incentive competition of all time, aiming to reward the brightest minds of space entrepreneurs to create a new era of economical and easy access to the Moon. Our correspondent, Dr. New Jaa Yien, spoke to the Malaysian team of Independence-X Team, currently led by the Founder and CEO of Independence-X Aerospace Sdn. Bhd., Mr. Mohd. Izmir Yamin, on the team’s progress in racing to the final stage of the competition.

Current Progress on Malaria Vaccines

Current Progress on Malaria Vaccines

Non-vaccine approaches for tackling malaria have made an impact in reducing the number of malaria cases and deaths but a vaccine would help tremendously towards malaria elimination. New sources of funding such as those from the Bill and Melinda Gates Foundation, pharmaceutical companies and oil companies in the last decade has enabled rapid advances in malaria vaccine development. We are likely to see the RTS,S/AS01 vaccine to be licensed for use in the next few years despite its low efficacy.

Teaching Your Immune System to Fight Cancer

Teaching Your Immune System to Fight Cancer

by Litt-Yee Hiew Our immune system is naturally gifted with remarkable specificity, potency and memory. So far, no pharmacological treatment for any diseases could possibly provide comparable level of safety, efficacy and lasting effects as the human immune response. In the treatment of cancer, after […]

The Imitation

The Imitation

by Nur Atikah Abdullah, Charles George Gajim, and Seti Faezah Rosli Disclaimer: the following article is a fictional piece that may or may not be scientifically accurate. Reading with discretion is advised. At a Glance: The idea of vaccination has always been heavily debated throughout the […]

Snake antivenoms: science, values and challenges

Snake antivenoms: science, values and challenges

Bites from venomous snakes can lead to snakebite envenomation (not poisoning), and antivenom is the only definitive therapy to date. Antivenoms used in current clinical practices are derived from antibodies of animals (e.g. horses) that have been immunised with one or a mix of snake venoms. However, the production of these biologics is highly costly, and there is no universal antivenom, as the effectiveness is limited by the different snake species and their geographical locality. The production and use of antivenoms can be optimised by unravelling the complexity of venoms, especially their immunogenicity and the dynamics-kinetics of venom-antivenom interplay.